TN2009000129A1 - Indole compound - Google Patents

Indole compound

Info

Publication number: TN2009000129A1
Authority: TN; Tunisia
Prior art keywords: indole compound; present; glucokinase activator; agent; prodrug
Prior art date: 2006-10-19

Application number

TNP2009000129A

Other languages

English (en)

Inventor

Tsuneo Yasuma

Osamu Ujikawa

Masahiro Itoh

Kazuko Aoki

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-19

Filing date

2009-04-08

Publication date

2010-10-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39010108&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2009000129(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-04-08 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2010-10-18 Publication of TN2009000129A1 publication Critical patent/TN2009000129A1/fr

Links

-1 Indole compound Chemical class 0.000 title 1
SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 title 1
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 title 1
229940124828 glucokinase activator Drugs 0.000 abstract 2
208000008589 Obesity Diseases 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
235000020824 obesity Nutrition 0.000 abstract 1
239000008177 pharmaceutical agent Substances 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Obesity (AREA)
Hematology (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Indole Compounds (AREA)

TNP2009000129A 2006-10-19 2009-04-08 Indole compound TN2009000129A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2006285551		2006-10-19
PCT/JP2007/070772 WO2008050821A1 (fr)	2006-10-19	2007-10-18	Compose indole

Publications (1)

Publication Number	Publication Date
TN2009000129A1 true TN2009000129A1 (en)	2010-10-18

Family

ID=39010108

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TNP2009000129A TN2009000129A1 (en)	2006-10-19	2009-04-08	Indole compound

Country Status (26)

Country	Link
US (4)	US7652133B2 (fr)
EP (2)	EP2508524A3 (fr)
JP (1)	JP5260507B2 (fr)
KR (1)	KR101444486B1 (fr)
CN (1)	CN101573357B (fr)
AU (1)	AU2007310064B2 (fr)
BR (1)	BRPI0717722A2 (fr)
CA (1)	CA2666973C (fr)
CL (1)	CL2008001017A1 (fr)
CR (1)	CR10748A (fr)
EC (1)	ECSP099330A (fr)
GE (1)	GEP20115241B (fr)
IL (1)	IL198154A (fr)
MA (1)	MA30890B1 (fr)
ME (1)	MEP11809A (fr)
MX (1)	MX2009003972A (fr)
MY (1)	MY158052A (fr)
NO (1)	NO20091948L (fr)
NZ (1)	NZ576570A (fr)
PE (1)	PE20090884A1 (fr)
RU (1)	RU2454415C9 (fr)
TN (1)	TN2009000129A1 (fr)
TW (1)	TWI460176B (fr)
UA (1)	UA97257C2 (fr)
WO (1)	WO2008050821A1 (fr)
ZA (1)	ZA200902585B (fr)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2008242983B2 (en) *	2007-04-16	2013-07-11	Abbvie Inc.	7-substituted indole Mcl-1 inhibitors
US8318746B2 (en)	2007-04-27	2012-11-27	Takeda Pharmaceutical Company Limited	Nitrogen-containing five-membered heterocyclic compound
EP2025674A1 (fr)	2007-08-15	2009-02-18	sanofi-aventis	Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
EP2178869B1 (fr) *	2007-08-17	2013-06-12	LG Life Sciences Ltd.	Composés d'indole en tant qu'inhibiteurs de nécrose cellulaire
US20100267708A1 (en) *	2007-12-20	2010-10-21	Lg Life Sciences Ltd.	Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
WO2009088192A2 (fr) *	2008-01-04	2009-07-16	Lg Life Sciences Ltd.	Dérivés d'indole et d'indolazole possédant un effet de conservation de cellules, de tissus et d'organes
WO2009097995A1 (fr) *	2008-02-07	2009-08-13	Sanofi-Aventis	Nouvelles imidazolidines substituées par un phényle, procédé de production, médicaments contenant ces composés et leur utilisation
PL2276760T3 (pl)	2008-04-10	2014-09-30	Takeda Pharmaceuticals Co	Związki z pierścieniem skondensowanym oraz ich zastosowanie
US8349886B2 (en) *	2008-04-16	2013-01-08	Takeda Pharmaceutical Company Limited	Nitrogenated 5-membered heterocyclic compound
AR072297A1 (es) *	2008-06-27	2010-08-18	Novartis Ag	Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
EP2323996B1 (fr) *	2008-08-18	2014-10-22	Promega Corporation	Composés luminogènes et procédés de détection des enzymes 3a du cytochrome p450
TW201014850A (en)	2008-09-25	2010-04-16	Takeda Pharmaceutical	Solid pharmaceutical composition
US8501804B2 (en)	2008-10-27	2013-08-06	Takeda Pharmaceutical Company Limited	Bicyclic compound
EP2371826A4 (fr)	2008-12-29	2012-06-27	Takeda Pharmaceutical	Nouveau composé cyclique condensé et utilisation de celui-ci
WO2010117085A1 (fr) *	2009-04-09	2010-10-14	Banyu Pharmaceutical Co.,Ltd.	Dérivés d'aryl-indole
EP2440541A1 (fr)	2009-06-09	2012-04-18	Takeda Pharmaceutical Company Limited	Nouveau composé cyclique fondu et son utilisation
JP5732394B2 (ja)	2009-07-28	2015-06-10	武田薬品工業株式会社	錠剤
WO2011107494A1 (fr)	2010-03-03	2011-09-09	Sanofi	Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
ES2546130T3 (es)	2010-04-27	2015-09-18	Takeda Pharmaceutical Company Limited	Derivados de compuestos bicíclicos y su uso como inhibidores de ACC
PH12012502468A1 (en)	2010-06-16	2015-05-08	Takeda Pharmaceuticals Co	Crystal of amide compound
WO2011159781A2 (fr) *	2010-06-17	2011-12-22	Senomyx, Inc.	Modulateurs de goût amer
US8933024B2 (en)	2010-06-18	2015-01-13	Sanofi	Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
EP2617726A4 (fr)	2010-09-17	2014-05-14	Takeda Pharmaceutical	Agent thérapeutique du diabète
SG190925A1 (en)	2010-11-30	2013-07-31	Takeda Pharmaceutical	Bicyclic compound
MX2013009526A (es)	2011-02-17	2013-10-01	Takeda Pharmaceutical	Metodo de produccion de derivado de dihidrobenzofurano opticamente activo.
WO2013037390A1 (fr)	2011-09-12	2013-03-21	Sanofi	Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
WO2013045413A1 (fr)	2011-09-27	2013-04-04	Sanofi	Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b] pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
WO2013057944A1 (fr) *	2011-10-19	2013-04-25	興和株式会社	Nouveau composé de spiroindoline, et agent thérapeutique le contenant
CA2853221A1 (fr)	2011-10-24	2013-05-02	Tohru Yamashita	Compose bicyclique
EP2802571A1 (fr)	2012-01-12	2014-11-19	Takeda Pharmaceutical Company Limited	Dérivés de benzimidazole comme antagonistes du récepteur mch
US9382188B2 (en)	2012-02-13	2016-07-05	Takeda Pharmaceutical Company Limited	Aromatic ring compound
EP2816032A4 (fr)	2012-02-13	2015-09-30	Takeda Pharmaceutical	Composé à noyaux aromatiques
JP6077555B2 (ja)	2012-02-15	2017-02-08	武田薬品工業株式会社	錠剤
CA2864990C (fr)	2012-02-24	2021-03-02	Nobuyuki Takakura	Composes de benzofurane et de benzothiophene pour l'inhibition de la ghreline o-acyltransferase (goat)
CN104350040B (zh)	2012-03-29	2016-06-01	武田药品工业株式会社	芳环化合物
JP6399660B2 (ja) *	2012-04-10	2018-10-03	ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア	癌治療用組成物および方法
WO2013168759A1 (fr)	2012-05-10	2013-11-14	武田薬品工業株式会社	Composé cyclique aromatique
US9505772B2 (en)	2012-05-10	2016-11-29	Takeda Pharmaceutical Company Limited	Aromatic ring compound
WO2013183784A1 (fr)	2012-06-05	2013-12-12	Takeda Pharmaceutical Company Limited	Préparation solide
JP2015127299A (ja)	2012-07-19	2015-07-09	武田薬品工業株式会社	固形製剤
WO2014085486A2 (fr)	2012-11-30	2014-06-05	Waters Technologies Corporation	Procédés et appareil pour l'analyse de métabolites de la vitamine d
EP2970331B1 (fr)	2013-03-14	2017-05-17	Takeda Pharmaceutical Company Limited	Dérivés de spiro azétidine isoxazole et leur utilisation en tant qu'antagonistes de sstr5
US10005720B2 (en)	2013-04-05	2018-06-26	North Carolina Central University	Compounds useful for the treatment of metabolic disorders and synthesis of the same
US9199963B2 (en)	2013-07-09	2015-12-01	Takeda Pharmaceutical Company Limited	Heterocyclic compound
LT3031799T (lt)	2013-08-09	2018-06-25	Takeda Pharmaceutical Company Limited	Aromatinis junginys
KR102001431B1 (ko) *	2013-08-22	2019-07-18	주식회사 엘지화학	세포괴사 저해제로서의 인돌아미드 화합물
JO3442B1 (ar)	2013-10-07	2019-10-20	Takeda Pharmaceuticals Co	مضادات ذات نوع فرعي من مستقبل سوماتوستاتين 5 (sstr5)
US9428470B2 (en)	2014-02-13	2016-08-30	Takeda Pharmaceutical Company Limited	Heterocyclic compound
US9346776B2 (en)	2014-02-13	2016-05-24	Takeda Pharmaceutical Company Limited	Fused heterocyclic compound
CN104098498A (zh) *	2014-07-30	2014-10-15	天津市斯芬克司药物研发有限公司	一种吲唑类化合物及其制备方法
JOP20180029A1 (ar)	2017-03-30	2019-01-30	Takeda Pharmaceuticals Co	مركب حلقي غير متجانس
WO2018181847A1 (fr)	2017-03-31	2018-10-04	武田薬品工業株式会社	Composé aromatique
AR111199A1 (es)	2017-03-31	2019-06-12	Takeda Pharmaceuticals Co	Compuesto aromático agonista de gpr40
JOP20180028A1 (ar)	2017-03-31	2019-01-30	Takeda Pharmaceuticals Co	مركب ببتيد
US11535660B1 (en)	2018-03-23	2022-12-27	Cannot Therapeutics, Inc.	Modulators of G-protein coupled receptors
JP6773938B2 (ja)	2018-08-27	2020-10-21	株式会社スコヒアファーマ	安息香酸エステル化合物
US12122815B2 (en)	2018-09-24	2024-10-22	Takeda Pharmaceutical Company Limited	GIP receptor agonist peptide compounds and uses thereof
EP3856339A1 (fr)	2018-09-24	2021-08-04	Takeda Pharmaceutical Company Limited	Composés peptidiques agonistes du récepteur gip et leurs utilisations
CN109250963B (zh) *	2018-09-29	2021-07-16	福建省昊立建设工程有限公司	一种复合增韧混凝土及其制备方法
PL4097099T3 (pl)	2020-02-07	2024-11-04	Gasherbrum Bio, Inc.	Heterocykliczne agonisty glp-1
WO2021193983A2 (fr)	2020-03-25	2021-09-30	Takeda Pharmaceutical Company Limited	Dosage d'une fois par semaine de composés peptidiques de l'agoniste du récepteur du gip et leurs utilisations
EP4126921A2 (fr)	2020-03-25	2023-02-08	Takeda Pharmaceutical Company Limited	Dosage d'une fois par jour de composés peptidiques de l'agoniste du récepteur du gip et leurs utilisations
CN113563306B (zh) *	2020-04-28	2022-07-01	新发药业有限公司	一种2-(4-苯氧基苯基)-6-(哌啶-4-)基烟酰胺的制备方法
CA3220005A1 (fr)	2021-05-13	2022-11-17	Carmot Therapeutics Inc.	Modulateurs de recepteurs couples a la proteine g
JP2025509281A (ja)	2022-03-09	2025-04-11	ガシャーブラム・バイオ・インコーポレイテッド	ヘテロ環式ｇｌｐ－１アゴニスト
WO2023179542A1 (fr)	2022-03-21	2023-09-28	Gasherbrum Bio , Inc.	Dérivés de 5,8-dihydro-1,7-naphtyridine utiles en tant qu'agonistes de glp-1 pour le traitement du diabète
JP2025513071A (ja)	2022-04-14	2025-04-22	ガシャーブラム・バイオ・インコーポレイテッド	ヘテロ環式ｇｌｐ－１アゴニスト
TW202435857A (zh)	2022-12-15	2024-09-16	美商迦舒布魯姆生物有限公司	具有glp-1促效劑活性之化合物之鹽及固體形式
WO2024131869A1 (fr)	2022-12-22	2024-06-27	Gasherbrum Bio, Inc.	Agonistes hétérocycliques du glp-1
WO2024138048A1 (fr)	2022-12-22	2024-06-27	Gasherbrum Bio, Inc.	Agonistes de glp-1 hétérocycliques
WO2024169952A1 (fr)	2023-02-16	2024-08-22	Gasherbrum Bio, Inc.	Agonistes hétérocycliques de glp-1
US20250019389A1 (en)	2023-06-30	2025-01-16	Gasherbrum Bio, Inc.	Heterocyclic agonists
WO2025015269A1 (fr)	2023-07-13	2025-01-16	Aconcagua Bio, Inc.	Composés, compositions et procédés
WO2025015268A1 (fr)	2023-07-13	2025-01-16	Aconcagua Bio, Inc.	Modulateurs de l'activité du récepteur de la calcitonine et/ou du récepteur de l'amyline
WO2025045208A1 (fr)	2023-08-31	2025-03-06	Gasherbrum Bio, Inc.	Agonistes de glp-1 à base de hétéroaryl-hétérocycloalkyl

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2656610B1 (fr) *	1989-12-29	1992-05-07	Sanofi Sa	Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
JP3545461B2 (ja) *	1993-09-10	2004-07-21	エーザイ株式会社	二環式ヘテロ環含有スルホンアミド誘導体
HU224069B1 (hu)	1993-09-10	2005-05-30	Eisai Co. Ltd.	Heterobiciklusos szulfonamid-származékok, eljárás előállításukra, ezeket hatóanyagként tartalmazó gyógyászati készítmények, valamint alkalmazásuk gyógyászati készítmények előállítására
AU6944296A (en)	1995-09-13	1997-04-01	Takeda Chemical Industries Ltd.	Benzoxazepine compounds, their production and use as lipid lowering agents
EP1062205A2 (fr) *	1998-02-25	2000-12-27	Genetics Institute, Inc.	Inhibiteurs d'enzymes phospholipases
JP4007743B2 (ja)	1999-02-26	2007-11-14	エーザイ・アール・アンド・ディー・マネジメント株式会社	血管新生阻害剤
AR035016A1 (es)	1999-08-25	2004-04-14	Takeda Chemical Industries Ltd	Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
GB0003636D0 (en) *	2000-02-16	2000-04-05	Smithkline Beecham Plc	Novel compounds
ATE479429T1 (de)	2000-04-28	2010-09-15	Takeda Pharmaceutical	Antagonisten des melanin-konzentrierenden hormons
EP1283199A4 (fr)	2000-05-16	2003-12-17	Takeda Chemical Industries Ltd	Antagoniste de l'hormone de concentration de la melanine
ES2293005T3 (es)	2002-10-03	2008-03-16	F. Hoffmann-La Roche Ag	Indol-3-carboxamidas como activadores de la glucocinasa.
EP1532980A1 (fr)	2003-11-24	2005-05-25	Novo Nordisk A/S	Carboxamides d'indole n-heteroarylé et leurs analogues, utiles comme des activateurs de glucokinase pour le traitement de diabetes
US7498445B2 (en) *	2004-05-05	2009-03-03	Renopharm Ltd.	Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof
EP1632491A1 (fr) *	2004-08-30	2006-03-08	Laboratorios Del Dr. Esteve, S.A.	composes indole substitues et leur utilisation comme modulateurs du recepteur 5-ht6
US8957070B2 (en) *	2005-04-20	2015-02-17	Takeda Pharmaceutical Company Limited	Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
WO2007037543A1 (fr)	2005-09-29	2007-04-05	Banyu Pharmaceutical Co., Ltd.	Dérivé de biarylamide
CA2623958C (fr)	2005-09-30	2013-05-28	Banyu Pharmaceutical Co., Ltd.	Derive indole substitue en position 2 par un groupe heteroaryle
JP5327652B2 (ja) *	2007-08-14	2013-10-30	バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	癌処理のための融合されたイミダゾール
PE20090944A1 (es) *	2007-08-14	2009-08-09	Bayer Schering Pharma Ag	PIRIMIDINAS BICICLICAS FUSIONADAS COMO INHIBIDORES DE LA VIA Pi3K/AKT
JO2784B1 (en) *	2007-10-18	2014-03-15	شركة جانسين فارماسوتيكا ان. في	5,3,1 - Triazole substitute derivative
RU2474579C2 (ru) *	2007-10-18	2013-02-10	Янссен Фармацевтика Нв	Тризамещенные 1,2,4-триазолы

2007
- 2007-10-18 AU AU2007310064A patent/AU2007310064B2/en not_active Ceased
- 2007-10-18 KR KR1020097010151A patent/KR101444486B1/ko not_active Expired - Fee Related
- 2007-10-18 EP EP12170280A patent/EP2508524A3/fr not_active Withdrawn
- 2007-10-18 JP JP2009515658A patent/JP5260507B2/ja not_active Expired - Fee Related
- 2007-10-18 US US11/907,929 patent/US7652133B2/en not_active Expired - Fee Related
- 2007-10-18 UA UAA200904957A patent/UA97257C2/ru unknown
- 2007-10-18 TW TW096138971A patent/TWI460176B/zh not_active IP Right Cessation
- 2007-10-18 WO PCT/JP2007/070772 patent/WO2008050821A1/fr active Application Filing
- 2007-10-18 ME MEP-118/09A patent/MEP11809A/xx unknown
- 2007-10-18 MY MYPI20091549A patent/MY158052A/en unknown
- 2007-10-18 GE GEAP200711259A patent/GEP20115241B/en unknown
- 2007-10-18 CN CN2007800470664A patent/CN101573357B/zh not_active Expired - Fee Related
- 2007-10-18 US US12/311,893 patent/US8410087B2/en not_active Expired - Fee Related
- 2007-10-18 ZA ZA200902585A patent/ZA200902585B/xx unknown
- 2007-10-18 CA CA2666973A patent/CA2666973C/fr not_active Expired - Fee Related
- 2007-10-18 MX MX2009003972A patent/MX2009003972A/es active IP Right Grant
- 2007-10-18 EP EP07830506A patent/EP2074119A1/fr not_active Withdrawn
- 2007-10-18 NZ NZ576570A patent/NZ576570A/en not_active IP Right Cessation
- 2007-10-18 BR BRPI0717722-4A patent/BRPI0717722A2/pt not_active IP Right Cessation
- 2007-10-18 RU RU2009118602/04A patent/RU2454415C9/ru not_active IP Right Cessation
2008
- 2008-04-10 CL CL2008001017A patent/CL2008001017A1/es unknown
- 2008-04-16 PE PE2008000659A patent/PE20090884A1/es not_active Application Discontinuation
2009
- 2009-03-19 US US12/382,622 patent/US7777047B2/en not_active Expired - Fee Related
- 2009-03-19 US US12/382,623 patent/US7718798B2/en not_active Expired - Fee Related
- 2009-04-08 TN TNP2009000129A patent/TN2009000129A1/fr unknown
- 2009-04-16 IL IL198154A patent/IL198154A/en not_active IP Right Cessation
- 2009-04-24 CR CR10748A patent/CR10748A/es unknown
- 2009-05-13 MA MA31871A patent/MA30890B1/fr unknown
- 2009-05-14 EC EC2009009330A patent/ECSP099330A/es unknown
- 2009-05-19 NO NO20091948A patent/NO20091948L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
UA97257C2 (en)	2012-01-25
CL2008001017A1 (es)	2009-04-24
CA2666973A1 (fr)	2008-05-02
EP2508524A3 (fr)	2012-10-24
NO20091948L (no)	2009-07-13
IL198154A (en)	2014-08-31
CN101573357B (zh)	2013-01-23
RU2009118602A (ru)	2010-11-27
RU2454415C9 (ru)	2013-02-27
CR10748A (es)	2009-05-20
US20100144702A1 (en)	2010-06-10
CA2666973C (fr)	2015-03-31
PE20090884A1 (es)	2009-08-05
KR101444486B1 (ko)	2014-09-24
US7652133B2 (en)	2010-01-26
US20100137610A1 (en)	2010-06-03
AU2007310064A1 (en)	2008-05-02
KR20090068292A (ko)	2009-06-25
ZA200902585B (en)	2010-09-29
IL198154A0 (en)	2009-12-24
US20080096877A1 (en)	2008-04-24
MY158052A (en)	2016-08-30
US7777047B2 (en)	2010-08-17
AU2007310064A2 (en)	2009-06-04
WO2008050821A1 (fr)	2008-05-02
US20090286975A1 (en)	2009-11-19
TW200825071A (en)	2008-06-16
BRPI0717722A2 (pt)	2013-10-29
ECSP099330A (es)	2009-06-30
US8410087B2 (en)	2013-04-02
MA30890B1 (fr)	2009-11-02
EP2074119A1 (fr)	2009-07-01
NZ576570A (en)	2010-11-26
US7718798B2 (en)	2010-05-18
MX2009003972A (es)	2009-04-27
ME00681B (fr)	2011-12-20
JP2010506825A (ja)	2010-03-04
RU2454415C2 (ru)	2012-06-27
AU2007310064B2 (en)	2013-03-28
JP5260507B2 (ja)	2013-08-14
EP2508524A2 (fr)	2012-10-10
CN101573357A (zh)	2009-11-04
TWI460176B (zh)	2014-11-11
GEP20115241B (en)	2011-06-10
MEP11809A (en)	2011-12-20

Publication	Publication Date	Title
TN2009000129A1 (en)	2010-10-18	Indole compound
JO2681B1 (en)	2013-03-03	Indole derivatives
MX2010009736A (es)	2010-09-30	Compuesto heterociclico.
MY152475A (en)	2014-10-15	Fused ring compounds and use thereof
MX2009007180A (es)	2009-07-15	Agonistas del receptor acoplado a la proteina g de la piperidina.
MY154798A (en)	2015-07-31	Fused cyclic compounds
HK1158192A1 (en)	2012-07-13	Piperidine gpcr agonists
TW200732341A (en)	2007-09-01	Chemical compounds
TW200833675A (en)	2008-08-16	Nicotinamide derivatives
UA96152C2 (en)	2011-10-10	Dihydropyrazolopyrimidinone derivatives
GB0812642D0 (en)	2008-08-20	Compounds
TW200745067A (en)	2007-12-16	Novel compounds
MX2009012285A (es)	2009-12-15	Inhibidores de diacilglicerol aciltransferasa.
MY149648A (en)	2013-09-30	Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
HK1135703A1 (en)	2010-06-11	Piperidine gpcr agonists
WO2009016462A3 (fr)	2009-03-26	Bicyclolactames substitués
IL187005A0 (en)	2008-02-09	Diacylglycerol acyltransferase inhibitors
MX2010009922A (es)	2010-09-28	Activadores de piridazinona glucocinasa.
MX2010005649A (es)	2010-08-18	Compuestos novedosos como ligandos del receptor canabinoide y sus usos.
MX2010003440A (es)	2010-04-21	Compuesto inhibidor de glicogeno fosforilasa y composicion farmaceutica del mismo.
MX2010003442A (es)	2010-04-21	Compuesto inhibidor de fosforilasa de glicogeno y composicion farmaceutica del mismo.
MY158069A (en)	2016-08-30	Tricyclic compound and pharmaceutical use thereof
GEP20156222B (en)	2015-01-26	Pyrazole compound
MX2009013667A (es)	2010-03-22	Inhibidores triciclicos de hidroxiesteroide deshidrogenasas.
TN2011000294A1 (en)	2012-12-17	Arylcyclopropylacetamide derivatives useful as glucokinase activators